-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Poor sleep quality is common among patients with multiple sclerosis (PwMS) (up to 67%, more common than the general population (33%-45%), associated with lower health-related quality of life (HRQoL), and higher community Mortality
Two surveys from the Australian Multiple Sclerosis Longitudinal Study (AMSLS) were used
Poor sleep quality was common (67%)
Sleep has a major impact on HRQoL, so interventions to improve sleep need to be developed
Poor sleep quality was not consistent with common MS symptoms; it was strongly associated with HRQoL and not with other symptoms